Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Atherosclerosis. 2020 Dec 1;316:53–57. doi: 10.1016/j.atherosclerosis.2020.11.016

Table 1.

Descriptive characteristics of subjects with peripheral artery disease and control subjects without known atherosclerotic cardiovascular disease.

No ASCVD PAD p =
n=19 n=239
Age, mean (SD), years 63.2 (6.3) 72.3 (10.9) <0.001
Female sex, n (%) 7 (37%) 78 (32.6%) 0.81
BMI, mean (SD), kg/m2 29.9 (5.1) 26.7 (5.3) 0.01
LDL-cholesterol, mean (SD), mg/dL 77 (42) 68 (25) 0.47
HDL-cholesterol, mean (SD), mg/dL 55 (17) 43 (13) 0.006
Triglycerides, median [range], mg/dL 116 [35, 259] 94 [31, 349] 0.20
Hypertension, n (%) 11 (57.9) 205 (85.8) 0.002
Hyperlipidemia, n (%) 12 (63.2) 177 (74.1) 0.34
Diabetes, n (%) 3 (15.8) 118 (49.4) 0.002
Insulin use, n (%) 0 (0.0) 75 (31.4) -
Coronary artery disease, n (%) 0 (0.0) 133 (55.6) -
Prior myocardial infarction, n (%) 0 (0.0) 55 (23.0) -
Current smokers, n (%) 1 (5.3) 38 (15.9) 0.20
Statin use, n (%) 11 (57.9) 193 (80.7) 0.02
Aspirin use, n (%) 10 (52.6) 208 (87.0) <0.001
Clopidogrel use, n (%) 0 (0.0) 90 (37.7) -

SI conversion factors: To convert cholesterol to mmol/L, multiply values by 0.0259.

ASCVD – atherosclerotic cardiovascular disease

BMI – body mass index

LDL – low density lipoprotein

HDL – high density lipoprotein

PAD – peripheral artery disease

SD – standard deviation